Jorge Findor

886 total citations
33 papers, 652 citations indexed

About

Jorge Findor is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Jorge Findor has authored 33 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 17 papers in Epidemiology and 6 papers in Rheumatology. Recurrent topics in Jorge Findor's work include Liver Disease Diagnosis and Treatment (14 papers), Liver Diseases and Immunity (14 papers) and Hepatitis C virus research (6 papers). Jorge Findor is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Liver Diseases and Immunity (14 papers) and Hepatitis C virus research (6 papers). Jorge Findor collaborates with scholars based in Argentina, United States and Sweden. Jorge Findor's co-authors include Juan Sordá, Rubén Terg, Jorge Daruich, Alberto Muñoz, Hugo Tanno, Hugo Fainboim, Marcelo J. Pando, Leonardo Fainboim, Margarita Ramonet and J. Larriba and has published in prestigious journals such as Hepatology, Gut and Journal of Hepatology.

In The Last Decade

Jorge Findor

33 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge Findor Argentina 12 410 361 119 104 58 33 652
Chao H. Chan United States 12 115 0.3× 153 0.4× 44 0.4× 87 0.8× 93 1.6× 16 467
Yona Kitay‐Cohen Israel 14 200 0.5× 244 0.7× 34 0.3× 55 0.5× 58 1.0× 44 589
A Musca Italy 13 230 0.6× 223 0.6× 41 0.3× 69 0.7× 8 0.1× 34 466
Alessandro Pampana Italy 8 322 0.8× 260 0.7× 129 1.1× 32 0.3× 31 0.5× 17 520
S.G. Hübscher United Kingdom 10 250 0.6× 327 0.9× 39 0.3× 210 2.0× 26 0.4× 27 583
Pietro Solero Italy 8 267 0.7× 213 0.6× 23 0.2× 56 0.5× 21 0.4× 9 621
Elisabetta Fontanini Italy 14 448 1.1× 550 1.5× 100 0.8× 41 0.4× 85 1.5× 28 834
İbrahim Hatemı Türkiye 15 88 0.2× 286 0.8× 193 1.6× 141 1.4× 32 0.6× 78 720
Nicola Bizzaro Italy 12 64 0.2× 90 0.2× 47 0.4× 72 0.7× 21 0.4× 26 477
Naomi Kawaguchi Japan 12 297 0.7× 271 0.8× 97 0.8× 77 0.7× 23 0.4× 28 477

Countries citing papers authored by Jorge Findor

Since Specialization
Citations

This map shows the geographic impact of Jorge Findor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Findor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Findor more than expected).

Fields of papers citing papers by Jorge Findor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Findor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Findor. The network helps show where Jorge Findor may publish in the future.

Co-authorship network of co-authors of Jorge Findor

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Findor. A scholar is included among the top collaborators of Jorge Findor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Findor. Jorge Findor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Findor, Jorge, et al.. (2002). Familial association in autoimmune liver disease.. PubMed. 62(3). 241–4. 8 indexed citations
2.
Terg, Rubén, et al.. (2002). Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. Journal of Hepatology. 37(6). 717–722. 120 indexed citations
3.
Findor, Jorge, et al.. (2002). Familial association in autoimmune liver disease. Journal of Hepatology. 36. 170–170. 5 indexed citations
4.
Findor, Jorge, et al.. (2002). Primary biliary cirrhosis and hepatocellular carcinoma. Autoimmunity Reviews. 1(4). 220–225. 25 indexed citations
5.
Fernández, José Luís, et al.. (2002). Use of a mathematical model to estimate the time of response to the treatment of chronic hepatitis C. Journal of Hepatology. 36. 234–234. 1 indexed citations
6.
Leung, Patrick S.C., Gordon D. Benson, Jorge Findor, et al.. (2000). Mucosal Immunity and Primary Biliary Cirrhosis: Presence of Antimitochondrial Antibodies in Urine. Hepatology. 32(5). 910–915. 60 indexed citations
7.
Daruich, Jorge, et al.. (2000). Erythrocytapheresis with Recombinant Human Erythropoietin in Hereditary Hemochromatosis Therapy: A New Alternative. Vox Sanguinis. 79(1). 40–45. 23 indexed citations
8.
Daruich, Jorge, Rey J, Roberto Herrera‐Goepfert, et al.. (2000). Erythrocytapheresis with Recombinant Human Erythropoietin in Hereditary Hemochromatosis Therapy: A New Alternative. Vox Sanguinis. 79(1). 40–45. 23 indexed citations
9.
Pando, Marcelo J., J. Larriba, Gabriela Fernández, et al.. (1999). Pediatric and adult forms of type I autoimmune hepatitis in argentina: Evidence for differential genetic predisposition. Hepatology. 30(6). 1374–1380. 153 indexed citations
10.
Bagur, A., C. Mautalén, Jorge Findor, Juan Sordá, & J. Somoza. (1998). Risk Factors for the Development of Vertebral and Total Skeleton Osteoporosis in Patients with Primary Biliary Cirrhosis. Calcified Tissue International. 63(5). 385–390. 41 indexed citations
11.
Findor, Jorge, et al.. (1997). Colestasis asociada a ticlopidina. Gastroenterología y Hepatología. 20(3). 2 indexed citations
12.
J, Rey, et al.. (1997). Prevalence of IgG Anti-HEV in Buenos Aires, a Nonendemic Area for Hepatitis E. Journal of Travel Medicine. 4(2). 100–101. 26 indexed citations
13.
Findor, Jorge, et al.. (1996). Response to Hepatitis A Vaccine in Children after a Single Dose with a Booster Administration 6 Months Later. Journal of Travel Medicine. 3(3). 156–159. 16 indexed citations
14.
Findor, Jorge. (1994). Interferon α-2a (IFN) and indomethacin (IMT) combination therapy for chronic hepatitis B (CHB). Pilot study. Hepatology. 19(4). I61–I61. 1 indexed citations
15.
Findor, Jorge, et al.. (1993). [Hepatitis B (HBV) and C (HBC) virus infections in Down's syndrome and in neuropsychiatric patients without Down's syndrome].. PubMed. 46(3). 208–12. 3 indexed citations
16.
Findor, Jorge, et al.. (1991). Intensive plasmapheresis as an alternative therapy for intractable pruritus of primary biliary cirrhosis. Transfusion Science. 12(3). 197–200. 6 indexed citations
17.
Findor, Jorge, et al.. (1974). Structure and ultrastructure of the liver in aged persons.. PubMed. 20(3). 200–4. 11 indexed citations
18.
Findor, Jorge, et al.. (1973). Isoenzymes of ?-glutamyl transpeptidase in liver diseases. Journal of Molecular Medicine. 51(6). 272–274. 9 indexed citations
19.
Findor, Jorge & E. Hultman. (1962). The Effect of Glucagon, Epinephrine and Vasopressine on the Plasma Concentration and Renal Excretion of Electrolytes in Man1. Scandinavian Journal of Clinical and Laboratory Investigation. 14(1). 59–65. 11 indexed citations
20.
Bergström, Jonas, Jorge Findor, & E. Hultman. (1961). The Contents of Glycogen and Potassium in Human Liver Tissue Obtained by Needle Biopsy. Scandinavian Journal of Clinical and Laboratory Investigation. 13(2). 353–354. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026